NRIX
Nurix Therapeutics, Inc. Common stock
$23.48
3.39%
+0.77
Notify me if price changes either direction
Buy NRIX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.4B
Enterprise value
2.0B
Trailing PE
-7.6918029785156
Forward PE
-10.268026
PEG Ratio
-0.13792198444235
Enterprise to EBITDA
-5.582
Enterprise to revenue
53.623
Price to book MRQ
5.848571
Price to sales TTM
64.104935
Financials
Fiscal Year Ends
2025-11-30
Most Recent Quarter (MRQ)
2026-05-31
Revenue (TTM)
36.8M
EBITDA
-353180000
Diluted EPS TTM
-3.46
Total Cash (MRQ)
443.5M
Current ratio (MRQ)
6.338
Operating Cash Flow (TTM)
-293704000
NRIX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
